NCT06359782 - Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Interventions

DRUG

C1 Esterase Inhibitor Injection [Cinryze]

C1 Esterase Inhibitor Injection \[Cinryze\]

DRUG

Placebo

Sodium Chloride /physiological saline (0.9%) in equal volume dosed intravenous

Trial Locations (1)

RECRUITING

Haaglanden Medical Centre, The Hague